NFKB1 and metabolic dysfunction-associated steatohepatitis: Additionally, the promoting effect of HIF‐2α on NASH may be mediated by the NF‐κB signaling pathway, which facilitates the progression of NASH to liver fibrosis and increases the expression of inflammation‐related genes.